Showing results (41-50 of 87) with videos related to
Sort By:
Pageof 9
Hepato-Gastroenterology|July 30, 2002
Intestinal metaplasia of the gastric cardia: a study from TurkeyDinc Dinçer, Fatih Besisik, Edibe Sahin, et al.International Journal of STD & AIDS|September 23, 2025
The impact of cART on hepatic steatosis and fibrosis in treatment-naïve PLwHIV: A prospective cohort studyMeryem Sahin Ozdemir, Yusuf Emre Ozdemir, Alperen Dogdas, et al.Annals of Hepatology|September 13, 2020
The effect of liver test abnormalities on the prognosis of COVID-19Alpay Medetalibeyoglu, Yunus Catma, Naci Senkal, et al.Antiviral Therapy|September 15, 2012
Efficacy of pegylated interferon-α treatment for 24 months in chronic delta hepatitis and predictors of responseCetin Karaca, Ozlem M Soyer, Bulent Baran, et al.The Journal of General Virology|September 19, 2013
Role of the line probe assay INNO-LiPA HBV DR and ultradeep pyrosequencing in detecting resistance mutations to nucleoside/nucleotide analogues in viral samples isolated from chronic hepatitis B patientsSevim Mese, Muzaffer Arikan, Aris Cakiris, et al.BMC Health Services Research|March 27, 2020
A micro-elimination approach to addressing hepatitis C in TurkeyRamazan Idilman, Homie Razavi, Sarah Robbins-Scott, et al.Journal of Neurogastroenterology and Motility|October 28, 2016
Belching in Irritable Bowel Syndrome: An Impedance StudyTuba Obekli, Filiz Akyuz, Umit Akyuz, et al.Hepato-Gastroenterology|July 13, 2004
Terlipressin and albumin combination treatment in hepatorenal syndromeAhmet Danalioglu, Yilmaz Cakaloglu, Cetin Karaca, et al.Journal of Clinical Gastroenterology|July 20, 2012
Association of the MEFV gene variations with inflammatory bowel disease in TurkeyFiliz Akyuz, Fatih Besisik, Duran Ustek, et al.Antimicrobial Agents and Chemotherapy|October 25, 2021
Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological StudyOguz Kagan Bakkaloglu, Ozgen Yildirim, Bilger Cavus, et al.Pageof 9